Tocqueville Asset Management L.P. Lantheus Holdings, Inc. Transaction History

Tocqueville Asset Management L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$55.54 - $72.65 $3.96 Million - $5.18 Million	-71,365 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$24.28 - $56.64 $1.48 Million - $3.45 Million	-60,855 Reduced 46.03%	71,365 $3.95 Million
Q4 2021 Feb 14, 2022	SELL	$22.54 - $30.44 $9,692 - $13,089	-430 Reduced 0.32%	132,220 $3.82 Million
Q3 2021 Nov 15, 2021	SELL	$24.23 - $28.59 $489,446 - $577,518	-20,200 Reduced 13.22%	132,650 $3.41 Million
Q2 2021 Aug 16, 2021	SELL	$19.51 - $27.64 $474,093 - $671,652	-24,300 Reduced 13.72%	152,850 $4.23 Million
Q1 2021 May 17, 2021	BUY	$13.77 - $21.66 $1.39 Million - $2.18 Million	100,630 Added 131.51%	177,150 $3.79 Million
Q4 2020 Feb 16, 2021	BUY	$10.75 - $14.91 $822,590 - $1.14 Million	76,520 New	76,520 $1.03 Million

545

70M

673K

454K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $5.63B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.